{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:50:57Z","timestamp":1791978657904,"version":"4.4.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1124\/dmd.113.051854","type":"journal-article","created":{"date-parts":[[2013,8,10]],"date-time":"2013-08-10T00:51:45Z","timestamp":1376095905000},"page":"1883-1887","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Characterization of Monocarboxylate Transporter 6: Expression in Human Intestine and Transport of the Antidiabetic Drug Nateglinide"],"prefix":"10.1016","volume":"41","author":[{"given":"Noriko","family":"Kohyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisae","family":"Shiokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Ohbayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuna","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinori","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.113.051854_bib2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1042\/bj3410529","article-title":"Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes","volume":"341","author":"Br\u00f6er","year":"1999","journal-title":"Biochem J"},{"key":"10.1124\/dmd.113.051854_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1042\/bj3330167","article-title":"Characterization of the monocarboxylate transporter 1 expressed in Xenopus laevis oocytes by changes in cytosolic pH","volume":"333","author":"Br\u00f6er","year":"1998","journal-title":"Biochem J"},{"key":"10.1124\/dmd.113.051854_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1042\/bj3500219","article-title":"The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells","volume":"350","author":"Dimmer","year":"2000","journal-title":"Biochem J"},{"key":"10.1124\/dmd.113.051854_bib5","first-page":"183","article-title":"Intraluminal pH of the human gastrointestinal tract","volume":"46","author":"Fallingborg","year":"1999","journal-title":"Dan Med Bull"},{"key":"10.1124\/dmd.113.051854_bib6","doi-asserted-by":"crossref","first-page":"G775","DOI":"10.1152\/ajpgi.2000.279.4.G775","article-title":"Mechanism(s) of butyrate transport in Caco-2 cells: role of monocarboxylate transporter 1","volume":"279","author":"Hadjiagapiou","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/dmd.113.051854_bib7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00424-003-1067-2","article-title":"The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond","volume":"447","author":"Halestrap","year":"2004","journal-title":"Pflugers Arch"},{"key":"10.1124\/dmd.113.051854_bib8","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bbamem.2004.12.005","article-title":"Intestinal uptake of nateglinide by an intestinal fluorescein transporter","volume":"1668","author":"Itagaki","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.113.051854_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1124\/jpet.104.074021","article-title":"H+-dependent transport mechanism of nateglinide in the brush-border membrane of the rat intestine","volume":"312","author":"Itagaki","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/dmd.113.051854_bib10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1124\/dmd.32.5.479","article-title":"Renal transport of organic compounds mediated by mouse organic anion transporter 3 (mOat3): further substrate specificity of mOat3","volume":"32","author":"Kobayashi","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051854_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2165\/00003088-200443020-00003","article-title":"Clinical pharmacokinetics of nateglinide: a rapidly-absorbed, short-acting insulinotropic agent","volume":"43","author":"McLeod","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/dmd.113.051854_bib13","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1124\/dmd.105.005264","article-title":"Functional characterization of human monocarboxylate transporter 6 (SLC16A5)","volume":"33","author":"Murakami","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.113.051854_bib14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/sj.bjp.0704875","article-title":"Transport and uptake of nateglinide in Caco-2 cells and its inhibitory effect on human monocarboxylate transporter MCT1","volume":"137","author":"Okamura","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1124\/dmd.113.051854_bib15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/bj3290321","article-title":"Cloning and sequencing of four new mammalian monocarboxylate transporter (MCT) homologues confirms the existence of a transporter family with an ancient past","volume":"329","author":"Price","year":"1998","journal-title":"Biochem J"},{"key":"10.1124\/dmd.113.051854_bib16","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.bbrc.2005.12.092","article-title":"Purification by p-aminobenzoic acid (PABA)-affinity chromatography and the functional reconstitution of the nateglinide\/H+ cotransport system in the rat intestinal brush-border membrane","volume":"340","author":"Saito","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.113.051854_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0014-2999(00)00119-9","article-title":"Inhibitory effect of novel oral hypoglycemic agent nateglinide (AY4166) on peptide transporters PEPT1 and PEPT2","volume":"392","author":"Terada","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/dmd.113.051854_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0014-2999(00)00324-1","article-title":"Inhibitory effect of anti-diabetic agents on rat organic anion transporter rOAT1","volume":"398","author":"Uwai","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/dmd.113.051854_bib19","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1248\/bpb1978.4.879","article-title":"A pharmacokinetic analysis program (multi) for microcomputer","volume":"4","author":"Yamaoka","year":"1981","journal-title":"J Pharmacobiodyn"},{"key":"10.1124\/dmd.113.051854_bib20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1006\/bbrc.1997.6588","article-title":"Identification of a unique monocarboxylate transporter (MCT3) in retinal pigment epithelium","volume":"234","author":"Yoon","year":"1997","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624115292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624115292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.113.051854","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T19:37:52Z","timestamp":1739907472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624115292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0090955624115292"],"URL":"https:\/\/doi.org\/10.1124\/dmd.113.051854","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of Monocarboxylate Transporter 6: Expression in Human Intestine and Transport of the Antidiabetic Drug Nateglinide","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.113.051854","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}